Drug Approval | November 27, 2025
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Fenebrutinib targets cells in the immune system known as B cells and microglia
Enabling a new era in minimally invasive obesity treatment across Europe
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Speakers are: Dr. Alok Khullar, Senior Technology Leader, Pidilite Industries; Dr. Kamlesh Pai Fondekar, Head - R&D, Godrej Agrovet; Dr. Hiten Mehta, Head - R&D (Chlor-Alkali), Aditya Birla Chemicals; Dr. Anil Kumar Soni, Head - Application Development, R&D, Clariant Chemicals India; Dr. Rupak Paul, Deputy General Manager – Formulation, Rallis India; Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals; and Pravin Prashant, Executive Editor, Indian Pharma Post
Subscribe To Our Newsletter & Stay Updated
